24.19
price up icon10.46%   2.29
after-market Handel nachbörslich: 24.40 0.21 +0.87%
loading

Finanzdaten der Vera Therapeutics Inc-Aktie (VERA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
40.12%
80.14
57.19 48.91 49.80 37.34
Operating Income/Loss
40.12%
-80.14
-57.19 -48.91 -49.80 -37.34
Nonoperating Income/Loss
34.36%
3.61
5.50 5.49 3.169 3.635
Income/Loss From Continuing Operations Before Tax
48.05%
-76.53
-51.69 -43.42 -46.63 -33.71
Income/Loss From Continuing Operations After Tax
48.05%
-76.53
-51.69 -43.42 -46.63 -33.71
Net Income/Loss
48.05%
-76.53
-51.69 -43.42 -46.63 -33.71
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.18%
63.79
63.67 1.7888 54.90 54.73
Diluted Average Shares
0.18%
63.79
63.67 1.7888 54.90 54.73
Basic Earnings Per Share
48.15%
-1.20
-0.81 -0.72 -0.85 -0.62
Diluted Earnings Per Share
48.15%
-1.20
-0.81 -0.72 -0.85 -0.62
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Kapitalisierung:     |  Volumen (24h):